Femtech Insider

Want to work in women's health? Here's your chance! 👇 Every Friday we share exciting opportunities from across the femtech and women's health innovation ecosystem. For more, visit our job board: https://lnkd.in/dK9gAiNy 🚀 Luma fertility is hiring a Senior Care Specialist. https://lnkd.in/gSKFeA-H 🚀 Equip is looking for a Payer Partnerships Manager. https://lnkd.in/gsdbq2Ju 🚀 Bobbie is hiring a VP, Growth. https://lnkd.in/gZ25iNWs 🚀 Bird&Be is hiring a Graphic Design Intern (Remote). https://lnkd.in/gdWPmhym 🚀 Everly Health is looking for a Director, Telehealth Operations. https://lnkd.in/gmnhqdYF 🚀 The Women's Hospital of Texas is hiring a Registered Nurse, Emergency Room. https://lnkd.in/gFeVHjtv 🚀 Cofertility is looking for a Member Experience Manager. https://lnkd.in/e6k7ebb8 🚀 Simplyhealth is looking for a Strategic Client Manager. https://lnkd.in/gyvCYnWf 🚀 SonderMind is looking for a Mental Health Therapist. https://lnkd.in/gSyjwiEY 🚀 Bayer is hiring a Senior Medical Science Liaison - Women's Healthcare. https://lnkd.in/gmfAc2Mg --- Want new jobs in the women's health ecosystem delivered straight to your inbox each week? Subscribe to our free Femtech Insider newsletter and never miss a beat! 👉 https://lnkd.in/dSPQJ53 #femtech #womenshealth #womenshealthinnovation #health #jobs #jobsearch #career #jobboard #womenshealthjobs #femtechjobs #healthcare #workinwomenshealth

🚨👋 Attention Health Companies! Do you work in communications at a European health company and do you use very large online platforms (VLOPS) such as Facebook, Instagram, TikTok, Linkedin, and Google to advertise your product or service? Have you faced digital suppression on social media when sharing essential health information? We want to hear your story! 🚀 The Case for Her, in partnership with the CensHERship campaign, is gathering insights from health innovators like you. Whether your content has been flagged as inappropriate, shadowbanned, or outright removed, we need to understand how censorship is impacting both women’s and men’s health content. Examples include: 💻 Flagging of accurate sexual health information as “explicit” or “inappropriate” content. 💻 Shadowbanning posts about menstruation, menopause, or erectile dysfunction—leaving followers unaware of these vital messages. 💻 Removal of ads or posts for reproductive health products with little to no explanation. CensHERship's last research made waves, landing in national media and sparking meetings with two major social media platforms. Now, we need your voice to push this forward, break down these barriers, and create a fair digital space for all. Take the survey below and let’s make a difference together! 👉 https://lnkd.in/dde98aRQ #femtech #womenshealth #womenshealthinnovation #healthcare #ecosystem #advertising #marketing #socialmedia #digitalhealth #ads #europe #socialnetworks #sponsored

🔬 Fellow Healthcare, a provider of mail-in semen analysis services, has announced it has delivered over 100,000 patient test results since its product launch in 2020. The company reports its testing volume has increased by more than 50% year-to-date from 2023. 📈 "We have always put scientific rigor first, designing a preservative solution that maintains sample integrity and ensures results are as accurate as if the sample was tested within one hour of being produced." Brian Hogan, Fellow Healthcare CEO #health #healthcare #healthcareinnovation #diagnostics #healthtech #biotech #athometesting #malefertility #fertility #reproductivehealth #growth #startup #scaleup

🤝 Scottish technology company iGii has announced a multi-million pound partnership with health monitoring company Prymexa to develop an at-home toolkit for early perimenopause detection. The collaboration aims to address a significant gap in menopause awareness and monitoring, with 60% of women under 40 reporting they don’t feel informed about this life stage. 💡 💬 “Menopause receives a fraction of the investment compared to other medical fields, yet half the population will experience it and demand for effective management solutions is growing exponentially. “Our research aims to bring individuals closer to a simple, clear understanding of their menopause journey and how to best manage it.” Sara Pardoe, Prymexa CEO #femtech #womenshealth #womenshealthinnovation #femhealth #menopause #perimenopause #diagnostics #healthcare #healthcareinnovation #partnership

💰 Parallel Fluidics, a company developing on-demand microfluidic manufacturing solutions with applications in IVF and other life science fields, has secured $7 million in seed funding. The round was led by J2 Ventures with participation from 8VC and Praxis. 🤝 💬 “In order to provide advanced care in fertility treatments such as IVF, precise fluid control and the ability to manage sensitive biological samples without being wasteful are critical. Solutions like Parallel Fluidics’ microfluidic systems are filling that gap with their microvalves and enabling faster, more reliable processes that can help us enhance patient outcomes and drive innovation in reproductive medicine.” Lionel Matthys, CPO at Overture Life Jonathan Bronson Joshua G. #femtech #reproductivehealth #fertility #health #healthtech #biotech #ivf #ivfclinic #investment #investor #vc #venturecapital #startup #seedround

🤔 Curious what's been up in the world of femtech and women's health innovation this week? Here's the our run-down! 👇 💦 Persperity Health, Inc raises $1M to develop sweat-based hormone monitoring technology. https://lnkd.in/grdmcJgt 💰 Vara secures $8.9M to expand AI breast cancer detection platform in emerging markets. https://lnkd.in/gGBKSXEE 🤝 Caldera Medical acquires UVision360 to expand hysteroscopy portfolio. https://lnkd.in/g6adTNqd 💰 Venture Life Group plc acquires Health & Her Ltd for £10M to expand women’s health portfolio. https://lnkd.in/g-9k4z98 🚀 Noom adds AI body scan feature to monitor body composition changes during weight loss. https://lnkd.in/gCEbmVBJ 🤝 Femasys Inc. partners with Boston IVF to expand access to novel fertility treatment. https://lnkd.in/geff6SR7 🚀 Wisp launches weight care services targeting hormone-related weight management. https://lnkd.in/gHt87YBc 🔍 The Case for Her and CensHERship are teaming up on a survey to better understand issues EU brands face when sharing health content on social media. https://lnkd.in/dde98aRQ #femtech #womenshealth #womenshealthinnovation #health #healthcare #healthcareinnovation #femhealth #digitalhealth #healthtech #biotech #pharma #startup #scaleup #venturecapital #research #ecosysystem

🤝 Femasys Inc. has announced a strategic partnership with Boston IVF to offer FemaSeed, its FDA-cleared intratubal insemination product, across Boston IVF’s network of nearly 30 fertility centers in the U.S. The FemaSeed technology delivers sperm directly to the fallopian tube where conception naturally occurs. Clinical data has shown promising results, particularly for cases involving low male sperm count. 🔬 💬 "As pioneers in reproductive healthcare and research, our team at Boston IVF is always looking for innovative technologies that expand choices and improve potential outcomes for our patients. We believe additional options are needed in infertility treatment and believe FemaSeed will be a valuable addition to our suite of patient options." David Stern CEO #fertility #reproductivehealth #infertility #ttc #ivf #fertilityclinic #treatment #maleinfertility #malefertility #partnership #medtech #healthtech #biotech

🚀 Wisp, a women’s telehealth provider in the U.S., has announced the launch of a new weight care vertical specifically designed to address weight management challenges related to hormonal conditions. The new program specifically targets women struggling with hormonal conditions such as perimenopause, menopause, Polycystic Ovary Syndrome (PCOS), and endometriosis, offering personalized online consultations and access to four weight care solutions, including GLP-1 medications. 💡 💬 “Wisp is committed to providing sustainable support for women’s weight loss journeys, addressing a critical yet overlooked aspect of women’s health. As the dialogue around obesity evolves, we recognize that underlying conditions — especially hormonal imbalances linked to perimenopause and menopause — remain under-researched, underdiagnosed, and undertreated. With these new offerings, we’re proud to continue expanding access to comprehensive care, offering tailored solutions for every woman and every condition at every price point.” Monica Cepak, MBA, Wisp CEO #femtech #womenshealth #womenshealthinnovation #health #healthcare #obesity #weightloss #hormonehealth #health #healthtech #scaleup #telehealth

🔍 Digital healthcare company Noom has introduced a new body scan feature that enables users to track body composition changes using their smartphone camera, addressing growing attention to muscle mass retention during weight loss treatments. The launch coincides with broader trends in digital health, as more women’s health platforms expand their services to include weight management support. 💡 💬 “GLP-1s are highly effective in driving weight loss, however, much of the weight lost is actually muscle mass,” explains Geoff Cook, Chief Executive Officer of Noom. “Our partnership with Prism Labs makes accurate body mapping available to everyone. Our Muscle Defense fitness program emphasizes resistance training and our thousands of high-protein recipes encourage healthy eating, but we needed a simple and accurate way to monitor muscle-mass retention.” Geoff Cook, Noom Co-founder & CEO #femtech #womenshealth #womenshealthinnovation #metabolichealth #weightloss #weightmanagement #launch #digitalhealth #healthtech #app #health #healthcare #feature #ecosystem

🤝 Venture Life Group plc has announced the acquisition of Health & Her Ltd for an upfront cash consideration of £7.5 million, with additional payments of up to £2.5 million tied to performance and retention milestones. The acquisition strengthens Venture Life’s position in the rapidly growing hormone health market. 🚀 💬 "We are thrilled by today’s announcement of the acquisition of H&H by VLG. Venture Life Group’s success and momentum in the self-care space, combined with their extensive retail and market reach, promise to further our mission to support the lives of millions of people around the world with the life-affecting impact of hormone change. Joining VLG opens up extensive opportunities for synergies – particularly within the female health category alongside the VLG brand Balance Activ. We’re confident that our combined strengths will bring significant value to our customers and key stakeholders as we embark on this exciting new chapter." Kate Bache & Gervase Fernandes, Co-founders of Health & Her Ltd #femtech #womenshealth #womenshealthinnovation #health #healthcare #healthtech #ecommerce #consumerhealth #menopause #perimenopause #menstrualhealth #hormonehealth #acquisition #exit